{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T05:02:35Z","timestamp":1776920555586,"version":"3.51.2"},"reference-count":81,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,13]],"date-time":"2021-06-13T00:00:00Z","timestamp":1623542400000},"content-version":"am","delay-in-days":377,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-17-CE37-003-01 EPI_young"],"award-info":[{"award-number":["ANR-17-CE37-003-01 EPI_young"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["L'Enc\u00e9phale"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.encep.2019.11.009","type":"journal-article","created":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T17:41:15Z","timestamp":1583516475000},"page":"209-216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Lipides membranaires dans la schizophr\u00e9nie et la psychose d\u00e9butante\u00a0: de potentiels biomarqueurs et pistes th\u00e9rapeutiques\u00a0?"],"prefix":"10.1016","volume":"46","author":[{"given":"A.","family":"Frajerman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Kebir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Chaumette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Tessier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Lamazi\u00e8re","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Nuss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.-O.","family":"Krebs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.encep.2019.11.009_bib0410","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S0140-6736(77)92228-0","article-title":"Schizophrenia as a prostaglandin deficiency disease","volume":"1","author":"Horrobin","year":"1977","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.encep.2019.11.009_bib0415","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0920-9964(94)90043-4","article-title":"The membrane hypothesis of schizophrenia","volume":"13","author":"Horrobin","year":"1994","journal-title":"Schizophr Res"},{"key":"10.1016\/j.encep.2019.11.009_bib0420","doi-asserted-by":"crossref","unstructured":"Sethi S, Hayashi MAF, Barbosa BS, et al. Lipidomics, Biomarkers, and Schizophrenia: A Current Perspective. In: Sussulini A (ed) Metabolomics: From Fundamentals to Clinical Applications. Cham: Springer International Publishing, 2017, 265-290.","DOI":"10.1007\/978-3-319-47656-8_11"},{"key":"10.1016\/j.encep.2019.11.009_bib0425","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1194\/jlr.E400004-JLR200","article-title":"A comprehensive classification system for lipids","volume":"46","author":"Fahy","year":"2005","journal-title":"J Lipid Res"},{"key":"10.1016\/j.encep.2019.11.009_bib0430","doi-asserted-by":"crossref","first-page":"198","DOI":"10.2174\/157339907781368968","article-title":"Omega-3\u00a0fatty acids for nutrition and medicine: considering microalgae oil as a vegetarian source of EPA and DHA","volume":"3","author":"Doughman","year":"2007","journal-title":"Curr Diabetes Rev"},{"key":"10.1016\/j.encep.2019.11.009_bib0435","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.bbalip.2015.02.007","article-title":"Measuring brain lipids. Biochim Biophys Acta BBA","volume":"1851","author":"Dawson","year":"2015","journal-title":"Mol Cell Biol Lipids"},{"key":"10.1016\/j.encep.2019.11.009_bib0440","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.2741\/3878","article-title":"Omega-3\u00a0polyunsaturated fatty acids in the brain: metabolism and neuroprotection","volume":"16","author":"Zhang","year":"2011","journal-title":"Front Biosci Landmark Ed"},{"key":"10.1016\/j.encep.2019.11.009_bib0445","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/npp.2014.196","article-title":"Transgenic increase in n-3\/n-6\u00a0fatty acid ratio protects against cognitive deficits induced by an immune challenge through decrease of neuroinflammation","volume":"40","author":"Delpech","year":"2015","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.encep.2019.11.009_bib0450","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.plefa.2012.05.008","article-title":"n-3\u00a0Polyunsaturated fatty acids in animal models with neuroinflammation","volume":"88","author":"Orr","year":"2013","journal-title":"Prostaglandins Leukot Essent Fat Acids PLEFA"},{"key":"10.1016\/j.encep.2019.11.009_bib0455","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.plipres.2013.10.002","article-title":"Long-chain polyunsaturated fatty acids (LCPUFA) from genesis to senescence: the influence of LCPUFA on neural development, aging, and neurodegeneration","volume":"53","author":"Janssen","year":"2014","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.encep.2019.11.009_bib0460","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S0022-2275(20)32132-5","article-title":"Developmental changes in rat brain membrane lipids and fatty acids: the preferential prenatal accumulation of docosahexaenoic acid","volume":"40","author":"Green","year":"1999","journal-title":"J Lipid Res"},{"key":"10.1016\/j.encep.2019.11.009_bib0465","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.plefa.2006.07.005","article-title":"Omega-3\u00a0fatty acids and monoamine neurotransmission","volume":"75","author":"Chalon","year":"2006","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.encep.2019.11.009_bib0470","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.plefa.2003.12.011","article-title":"Docosahexaenoic acid in the diet: its importance in maintenance and restoration of neural membrane function","volume":"70","author":"Horrocks","year":"2004","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.encep.2019.11.009_bib0475","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/355722a0","article-title":"Potentiation of NMDA receptor currents by arachidonic acid","volume":"355","author":"Miller","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.encep.2019.11.009_bib0480","first-page":"23","article-title":"Myelin, copper, and the cuprizone model of schizophrenia","volume":"3","author":"Herring","year":"2011","journal-title":"Front Biosci Sch Ed"},{"key":"10.1016\/j.encep.2019.11.009_bib0485","doi-asserted-by":"crossref","unstructured":"Castillo RI, Rojo LE, Henriquez-Henriquez M, et al. From Molecules to the Clinic: Linking Schizophrenia and Metabolic Syndrome through Sphingolipids Metabolism. Front Neurosci; 10. Epub ahead of print 8\u00a0November 2016. DOI: 10.3389\/fnins.2016.00488.","DOI":"10.3389\/fnins.2016.00488"},{"key":"10.1016\/j.encep.2019.11.009_bib0490","doi-asserted-by":"crossref","first-page":"11321","DOI":"10.1073\/pnas.1734008100","article-title":"Modification by docosahexaenoic acid of age-induced alterations in gene expression and molecular composition of rat brain phospholipids","volume":"100","author":"Barcel\u00f3-Coblijn","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.encep.2019.11.009_bib0495","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.brainres.2012.09.002","article-title":"Maternal intake of Omega-3\u00a0essential fatty acids improves long term potentiation in the dentate gyrus and Morris water maze performance in rats","volume":"1482","author":"Kavraal","year":"2012","journal-title":"Brain Res"},{"key":"10.1016\/j.encep.2019.11.009_bib0500","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.neuroscience.2013.11.049","article-title":"Omega-3\u00a0prevents behavior response and brain oxidative damage in the ketamine model of schizophrenia","volume":"259","author":"Zugno","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.encep.2019.11.009_bib0505","doi-asserted-by":"crossref","first-page":"e36861","DOI":"10.1371\/journal.pone.0036861","article-title":"Short-term long chain omega3\u00a0diet protects from neuroinflammatory processes and memory impairment in aged mice","volume":"7","author":"Labrousse","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.encep.2019.11.009_bib0510","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nn.2736","article-title":"Nutritional omega-3\u00a0deficiency abolishes endocannabinoid-mediated neuronal functions","volume":"14","author":"Lafourcade","year":"2011","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.encep.2019.11.009_bib0515","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s13105-012-0179-6","article-title":"Nutritional n-3\u00a0polyunsaturated fatty acids deficiency alters cannabinoid receptor signaling pathway in the brain and associated anxiety-like behavior in mice","volume":"68","author":"Larrieu","year":"2012","journal-title":"J Physiol Biochem"},{"key":"10.1016\/j.encep.2019.11.009_bib0520","first-page":"3516","article-title":"Amplification of mGlu 5 -endocannabinoid signaling rescues behavioral and synaptic deficits in a mouse model of adolescent and adult dietary polyunsaturated fatty acids imbalance","author":"Manduca","year":"2017","journal-title":"J Neurosci"},{"key":"10.1016\/j.encep.2019.11.009_bib0525","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0952-3278(03)00056-5","article-title":"n-3\u00a0Polyunsaturated fatty acid (PUFA) deficiency elevates and n-3\u00a0PUFA enrichment reduces brain 2-arachidonoylglycerol level in mice","volume":"69","author":"Watanabe","year":"2003","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.encep.2019.11.009_bib0530","doi-asserted-by":"crossref","unstructured":"Bondi CO, Taha AY, Tock JL, et al. Adolescent behavior and dopamine availability are uniquely sensitive to dietary omega-3\u00a0fatty acid deficiency. Biol Psychiatry; 75. Epub ahead of print 1\u00a0January 2014. DOI: 10.1016\/j.biopsych.2013.06.007.","DOI":"10.1016\/j.biopsych.2013.06.007"},{"key":"10.1016\/j.encep.2019.11.009_bib0535","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.plefa.2006.07.006","article-title":"Omega-3\u00a0fatty acids and rodent behavior","volume":"75","author":"Fedorova","year":"2006","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.encep.2019.11.009_bib0540","doi-asserted-by":"crossref","first-page":"e437","DOI":"10.1038\/tp.2014.77","article-title":"Nutritional omega-3\u00a0modulates neuronal morphology in the prefrontal cortex along with depression-related behaviour through corticosterone secretion","volume":"4","author":"Larrieu","year":"2014","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.encep.2019.11.009_bib0545","doi-asserted-by":"crossref","first-page":"e1229","DOI":"10.1038\/tp.2017.182","article-title":"Polyunsaturated fatty acid deficiency during neurodevelopment in mice models the prodromal state of schizophrenia through epigenetic changes in nuclear receptor genes","volume":"7","author":"Maekawa","year":"2017","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.encep.2019.11.009_bib0550","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1162\/0898929041920441","article-title":"Maturation of white matter is associated with the development of cognitive functions during childhood","volume":"16","author":"Nagy","year":"2004","journal-title":"J Cogn Neurosci"},{"key":"10.1016\/j.encep.2019.11.009_bib0555","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/nn1426","article-title":"High cholesterol level is essential for myelin membrane growth","volume":"8","author":"Saher","year":"2005","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.encep.2019.11.009_bib0560","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.neuroscience.2013.11.007","article-title":"Role of myelin plasticity in oscillations and synchrony of neuronal activity","volume":"276","author":"Pajevic","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.encep.2019.11.009_bib0565","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.plefa.2013.11.004","article-title":"Eicosapentaenoic acid pre-treatment reduces biochemical changes induced in total brain and myelin of weanling Wistar rats by cuprizone feeding","volume":"90","author":"Di Biase","year":"2014","journal-title":"Prostaglandins Leukot Essent Fat Acids PLEFA"},{"key":"10.1016\/j.encep.2019.11.009_bib0570","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.pnpbp.2009.05.006","article-title":"Demyelination in the juvenile period, but not in adulthood, leads to long-lasting cognitive impairment and deficient social interaction in mice","volume":"33","author":"Makinodan","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.encep.2019.11.009_bib0575","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1093\/schbul\/sbs089","article-title":"Polyunsaturated Fatty Acid Concentration Predicts Myelin Integrity in Early-Phase Psychosis","volume":"39","author":"Peters","year":"2013","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.encep.2019.11.009_bib0580","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psychres.2012.09.041","article-title":"Red blood cell polyunsaturated fatty acids measured in red blood cells and schizophrenia: a meta-analysis","volume":"207","author":"Hoen","year":"2013","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.encep.2019.11.009_bib0585","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.jpsychires.2013.01.016","article-title":"Altered fatty acid concentrations in prefrontal cortex of schizophrenic patients","volume":"47","author":"Taha","year":"2013","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.encep.2019.11.009_bib0590","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jpsychires.2015.06.014","article-title":"Phosphorus magnetic resonance spectroscopy studies in schizophrenia","volume":"68","author":"Yuksel","year":"2015","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.encep.2019.11.009_bib0595","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.atherosclerosis.2017.05.007","article-title":"The Omega-3\u00a0Index and relative risk for coronary heart disease mortality: estimation from 10\u00a0cohort studies","volume":"262","author":"Harris","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.encep.2019.11.009_bib0600","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12944-016-0196-5","article-title":"Detection and treatment of omega-3\u00a0fatty acid deficiency in psychiatric practice: rationale and implementation","volume":"15","author":"Messamore","year":"2016","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.encep.2019.11.009_bib0605","first-page":"CD012345","article-title":"Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease","volume":"7","author":"Abdelhamid","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.encep.2019.11.009_bib0610","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1212\/WNL.0b013e318249f6a9","article-title":"Red blood cell \u03c9-3\u00a0fatty acid levels and markers of accelerated brain aging","volume":"78","author":"Tan","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.encep.2019.11.009_bib0615","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.3945\/ajcn.2009.28549","article-title":"Docosahexaenoic acid supplementation increases prefrontal cortex activation during sustained attention in healthy boys:a placebo-controlled, dose-ranging, functional magnetic resonance imaging study","volume":"91","author":"McNamara","year":"2010","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.encep.2019.11.009_bib0620","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.neuroscience.2016.12.007","article-title":"Polyunsaturated fatty acid biostatus, phospholipase A2\u00a0activity and brain white matter microstructure across adolescence","volume":"343","author":"McNamara","year":"2017","journal-title":"Neuroscience"},{"key":"10.1016\/j.encep.2019.11.009_bib0625","doi-asserted-by":"crossref","unstructured":"Wood PL, Holderman NR. Dysfunctional glycosynapses in schizophrenia: Disease and regional specificity. Schizophr Res. Epub ahead of print 21\u00a0May 2015. DOI: 10.1016\/j.schres.2015.05.017.","DOI":"10.1016\/j.schres.2015.05.017"},{"key":"10.1016\/j.encep.2019.11.009_bib0630","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.biopsych.2013.03.003","article-title":"Myelin and Axon Abnormalities in Schizophrenia Measured with Magnetic Resonance Imaging Techniques","volume":"74","author":"Du","year":"2013","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.encep.2019.11.009_bib0635","doi-asserted-by":"crossref","first-page":"e906","DOI":"10.1038\/tp.2016.142","article-title":"Membrane lipidomics in schizophrenia patients: a correlational study with clinical and cognitive manifestations","volume":"6","author":"Tessier","year":"2016","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.encep.2019.11.009_bib0640","doi-asserted-by":"crossref","unstructured":"Sun L, Yang X, Jiang J, et al. Identification of the Niacin-Blunted Subgroup of Schizophrenia Patients from Mood Disorders and Healthy Individuals in Chinese Population. Schizophr Bull, 2018. DOI: 10.1093\/schbul\/sbx150.","DOI":"10.1093\/schbul\/sbx150"},{"key":"10.1016\/j.encep.2019.11.009_bib0645","first-page":"372","article-title":"Phospholipid membrane abnormalities and reduced niacin skin flush response in schizophrenia","volume":"20","author":"Bureti\u0107-Tomljanovi\u0107","year":"2008","journal-title":"Psychiatr Danub"},{"key":"10.1016\/j.encep.2019.11.009_bib0650","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1038\/sj.npp.1301343","article-title":"Cannabinoids influence lipid-arachidonic acid pathways in schizophrenia","volume":"32","author":"Smesny","year":"2007","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.encep.2019.11.009_bib0655","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0006-3223(99)00010-4","article-title":"Clinical subtyping reveals significant differences in calcium-dependent phospholipase A2\u00a0activity in schizophrenia","volume":"46","author":"Hudson","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.encep.2019.11.009_bib0660","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0006-3223(87)90164-8","article-title":"Increased plasma phospholipase-A2\u00a0activity in schizophrenic patients: reduction after neuroleptic therapy","volume":"22","author":"Gattaz","year":"1987","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.encep.2019.11.009_bib0665","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.neuroimage.2010.05.009","article-title":"Phospholipase A2\u00a0activity is associated with structural brain changes in schizophrenia","volume":"52","author":"Smesny","year":"2010","journal-title":"NeuroImage"},{"key":"10.1016\/j.encep.2019.11.009_bib0670","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/mp.2015.22","article-title":"Inflammation as a predictive biomarker for response to omega-3\u00a0fatty acids in major depressive disorder: a proof-of-concept study","volume":"21","author":"Rapaport","year":"2016","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.encep.2019.11.009_bib0675","doi-asserted-by":"crossref","first-page":"758","DOI":"10.3945\/jn.115.222562","article-title":"The Omega-3\u00a0Index Is Inversely Associated with Depressive Symptoms among Individuals with Elevated Oxidative Stress Biomarkers","volume":"146","author":"Bigornia","year":"2016","journal-title":"J Nutr"},{"key":"10.1016\/j.encep.2019.11.009_bib0680","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.schres.2017.03.031","article-title":"Lipid profile disturbances in antipsychotic-naive patients with first-episode non-affective psychosis: a systematic review and meta-analysis","volume":"190","author":"Misiak","year":"2017","journal-title":"Schizophr Res"},{"key":"10.1016\/j.encep.2019.11.009_bib0685","doi-asserted-by":"crossref","first-page":"e68717","DOI":"10.1371\/journal.pone.0068717","article-title":"Lipidomics Reveals Early Metabolic Changes in Subjects with Schizophrenia: Effects of Atypical Antipsychotics","volume":"8","author":"McEvoy","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.encep.2019.11.009_bib0690","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.4088\/JCP.v68n1206","article-title":"Ethyl-eicosapentaenoic acid in first-episode psychosis: a randomized, placebo-controlled trial","volume":"68","author":"Berger","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.encep.2019.11.009_bib0695","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1038\/sj.npp.1301628","article-title":"Ethyl-eicosapentaenoic acid in first-episode psychosis. A 1H-MRS study","volume":"33","author":"Berger","year":"2008","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.encep.2019.11.009_bib0700","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jpsychires.2015.11.013","article-title":"A randomized controlled study of the efficacy of six-month supplementation with concentrated fish oil rich in omega-3\u00a0polyunsaturated fatty acids in first episode schizophrenia","volume":"73","author":"Pawe\u0142czyk","year":"2016","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.encep.2019.11.009_bib0705","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.schres.2017.10.013","article-title":"Omega-3\u00a0fatty acid supplementation may prevent loss of gray matter thickness in the left parieto-occipital cortex in first episode schizophrenia: a secondary outcome analysis of the OFFER randomized controlled study","volume":"195","author":"Pawe\u0142czyk","year":"2018","journal-title":"Schizophr Res"},{"key":"10.1016\/j.encep.2019.11.009_bib0710","doi-asserted-by":"crossref","first-page":"598","DOI":"10.3109\/15622975.2010.541283","article-title":"Phospholipase A activity in first episode schizophrenia: associations with symptom severity and outcome at week 12","volume":"12","author":"Smesny","year":"2011","journal-title":"World J Biol Psychiatry"},{"key":"10.1016\/j.encep.2019.11.009_bib0715","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1186\/s12888-016-0932-4","article-title":"White matter integrity in individuals at ultra-high risk for psychosis: a systematic review and discussion of the role of polyunsaturated fatty acids","volume":"16","author":"Vijayakumar","year":"2016","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.encep.2019.11.009_bib0720","doi-asserted-by":"crossref","unstructured":"Chaumette B, Kebir O, Pouch J, et al. Longitudinal Analyses of Blood Transcriptome During Conversion to Psychosis. Schizophr Bull, 2019. DOI: 10.1093\/schbul\/sby009.","DOI":"10.1093\/schbul\/sby009"},{"key":"10.1016\/j.encep.2019.11.009_bib0725","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.psychres.2015.04.036","article-title":"Erythrocyte polyunsaturated fatty acid levels in young people at ultra-high risk for psychotic disorder and healthy adolescent controls","volume":"228","author":"Rice","year":"2015","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.encep.2019.11.009_bib0730","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/archgenpsychiatry.2009.192","article-title":"Long-chain omega-3\u00a0fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial","volume":"67","author":"Amminger","year":"2010","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.encep.2019.11.009_bib0735","doi-asserted-by":"crossref","first-page":"7934","DOI":"10.1038\/ncomms8934","article-title":"Longer-term outcome in the prevention of psychotic disorders by the Vienna omega-3\u00a0study","volume":"6","author":"Amminger","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.encep.2019.11.009_bib0740","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.schres.2017.08.010","article-title":"Predictors of longer-term outcome in the Vienna omega-3\u00a0high-risk study","volume":"193","author":"Mossaheb","year":"2018","journal-title":"Schizophr Res"},{"key":"10.1016\/j.encep.2019.11.009_bib0745","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/mp.2013.7","article-title":"Omega-3\u00a0fatty acid supplementation changes intracellular phospholipase A2\u00a0activity and membrane fatty acid profiles in individuals at ultra-high risk for psychosis","volume":"19","author":"Smesny","year":"2014","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.encep.2019.11.009_bib0750","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/jamapsychiatry.2016.2902","article-title":"Effect of \u03c9-3\u00a0Polyunsaturated Fatty Acids in Young People at Ultrahigh Risk for Psychotic Disorders: The NEURAPRO Randomized Clinical Trial","volume":"74","author":"McGorry","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.encep.2019.11.009_bib0755","unstructured":"Schl\u00f6gelhofer M, McGorry P, Smesny stefan, et al. The Neurapro Study: Adherence to Study Medication."},{"key":"10.1016\/j.encep.2019.11.009_bib0760","doi-asserted-by":"crossref","first-page":"e335","DOI":"10.1038\/tp.2013.110","article-title":"A randomized placebo-controlled trial of an omega-3\u00a0fatty acid and vitamins E+C in schizophrenia","volume":"3","author":"Bentsen","year":"2013","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.encep.2019.11.009_bib0765","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.euroneuro.2016.01.009","article-title":"Biomarkers for drug development in early psychosis: Current issues and promising directions","volume":"26","author":"Goff","year":"2016","journal-title":"Eur Neuropsychopharmacol J"},{"key":"10.1016\/j.encep.2019.11.009_bib0770","doi-asserted-by":"crossref","first-page":"e897","DOI":"10.1038\/tp.2016.170","article-title":"Prediction of transition from ultra-high risk to first-episode psychosis using a probabilistic model combining history, clinical assessment and fatty-acid biomarkers","volume":"6","author":"Clark","year":"2016","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.encep.2019.11.009_bib0775","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0920-9964(94)90084-1","article-title":"A red cell membrane abnormality in a subgroup of schizophrenic patients: evidence for two diseases","volume":"12","author":"Glen","year":"1994","journal-title":"Schizophr Res"},{"key":"10.1016\/j.encep.2019.11.009_bib0780","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.biopsych.2011.02.011","article-title":"Bimodal distribution of polyunsaturated fatty acids in schizophrenia suggests two endophenotypes of the disorder","volume":"70","author":"Bentsen","year":"2011","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.encep.2019.11.009_bib0785","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.psychres.2009.01.009","article-title":"Abnormal transbilayer distribution of phospholipids in red blood cell membranes in schizophrenia","volume":"169","author":"Nuss","year":"2009","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.encep.2019.11.009_bib0790","doi-asserted-by":"crossref","first-page":"e1240","DOI":"10.1038\/tp.2017.211","article-title":"Identification of a plasma signature of psychotic disorder in children and adolescents from the Avon Longitudinal Study of Parents and Children (ALSPAC) cohort","volume":"7","author":"O\u2019Gorman","year":"2017","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.encep.2019.11.009_bib0795","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.schres.2017.09.021","article-title":"A systematic review of metabolite biomarkers of schizophrenia","volume":"195","author":"Davison","year":"2018","journal-title":"Schizophr Res"},{"key":"10.1016\/j.encep.2019.11.009_bib0800","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.schres.2017.08.023","article-title":"Psychosis subgroups differ in intrinsic neural activity but not task-specific processing","volume":"195","author":"Hudgens-Haney","year":"2018","journal-title":"Schizophr Res"},{"key":"10.1016\/j.encep.2019.11.009_bib0805","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.plefa.2017.06.014","article-title":"The niacin response biomarker as a schizophrenia endophenotype: A status update","volume":"136","author":"Messamore","year":"2018","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.encep.2019.11.009_bib0405","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.plefa.2018.01.001","article-title":"Safety and tolerability of prescription omega-3\u00a0fatty acids: a systematic review and meta-analysis of randomized controlled trials","volume":"129","author":"Chang","year":"2018","journal-title":"Prostaglandins Leukot Essent Fatty Acids"}],"container-title":["L'Enc\u00e9phale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001370062030021X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001370062030021X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T17:37:50Z","timestamp":1757957870000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001370062030021X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":81,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S001370062030021X"],"URL":"https:\/\/doi.org\/10.1016\/j.encep.2019.11.009","relation":{},"ISSN":["0013-7006"],"issn-type":[{"value":"0013-7006","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipides membranaires dans la schizophr\u00e9nie et la psychose d\u00e9butante\u00a0: de potentiels biomarqueurs et pistes th\u00e9rapeutiques\u00a0?","name":"articletitle","label":"Article Title"},{"value":"L'Enc\u00e9phale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.encep.2019.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 L'Enc\u00e9phale, Paris.","name":"copyright","label":"Copyright"}]}}